Bank of America’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$153K Buy
80,316
+77,738
+3,015% +$148K ﹤0.01% 5351
2025
Q1
$18.3K Sell
2,578
-1,872
-42% -$13.3K ﹤0.01% 5963
2024
Q4
$97.9K Buy
4,450
+749
+20% +$16.5K ﹤0.01% 5539
2024
Q3
$74.3K Buy
3,701
+669
+22% +$13.4K ﹤0.01% 5559
2024
Q2
$52.8K Sell
3,032
-392
-11% -$6.82K ﹤0.01% 5651
2024
Q1
$143K Sell
3,424
-3,672
-52% -$153K ﹤0.01% 5225
2023
Q4
$178K Sell
7,096
-5,344
-43% -$134K ﹤0.01% 5216
2023
Q3
$407K Buy
12,440
+10,945
+732% +$358K ﹤0.01% 4613
2023
Q2
$87K Buy
+1,495
New +$87K ﹤0.01% 5408
2023
Q1
Sell
-9
Closed -$270 7291
2022
Q4
$270 Buy
+9
New +$270 ﹤0.01% 6671
2022
Q3
Hold
0
7196
2022
Q2
Sell
-208
Closed -$11K 7427
2022
Q1
$11K Sell
208
-106
-34% -$5.61K ﹤0.01% 6906
2021
Q4
$22K Sell
314
-259
-45% -$18.1K ﹤0.01% 6623
2021
Q3
$91K Sell
573
-178
-24% -$28.3K ﹤0.01% 5898
2021
Q2
$147K Sell
751
-306
-29% -$59.9K ﹤0.01% 5515
2021
Q1
$273K Buy
1,057
+402
+61% +$104K ﹤0.01% 5166
2020
Q4
$126K Buy
655
+131
+25% +$25.2K ﹤0.01% 5131
2020
Q3
$106K Sell
524
-48
-8% -$9.71K ﹤0.01% 5053
2020
Q2
$160K Buy
572
+367
+179% +$103K ﹤0.01% 4849
2020
Q1
$61K Sell
205
-5
-2% -$1.49K ﹤0.01% 5192
2019
Q4
$68K Buy
210
+7
+3% +$2.27K ﹤0.01% 5336
2019
Q3
$78K Buy
203
+73
+56% +$28K ﹤0.01% 5337
2019
Q2
$59K Buy
130
+59
+83% +$26.8K ﹤0.01% 5461
2019
Q1
$37K Buy
71
+53
+294% +$27.6K ﹤0.01% 5545
2018
Q4
$7K Buy
18
+11
+157% +$4.28K ﹤0.01% 5934
2018
Q3
$2K Buy
7
+2
+40% +$571 ﹤0.01% 6288
2018
Q2
$3K Buy
5
+3
+150% +$1.8K ﹤0.01% 6127
2018
Q1
$8K Buy
+2
New +$8K ﹤0.01% 5920